Method for diagnosing thromboembolic disorders and coronary heart diseases

Details for Australian Patent Application No. 2006301578 (hide)

Owner Sanofi-Aventis

Inventors Kozian, Detlef; Herrmann, Matthias

Agent Watermark

Pub. Number AU-B-2006301578

PCT Pub. Number WO2007/042165

Priority 10 2005 048 899.4 12.10.05 DE

Filing date 30 September 2006

Wipo publication date 19 April 2007

Acceptance publication date 1 December 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/042165 Priority application(s): WO2007/042165

1 December 2011 Application Accepted

  Published as AU-B-2006301578

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301579-EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases

2006301573-Retard formulation for pralnacasan